Trials / Completed
CompletedNCT00234897
Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,938 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adalimumab |
Timeline
- Start date
- 2004-08-01
- First posted
- 2005-10-10
- Last updated
- 2007-08-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00234897. Inclusion in this directory is not an endorsement.